These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7974621)

  • 1. Carisoprodol elimination in humans.
    Olsen H; Koppang E; Alvan G; Mørland J
    Ther Drug Monit; 1994 Aug; 16(4):337-40. PubMed ID: 7974621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of meprobamate from carisoprodol is catalysed by CYP2C19.
    Dalén P; Alvan G; Wakelkamp M; Olsen H
    Pharmacogenetics; 1996 Oct; 6(5):387-94. PubMed ID: 8946470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
    Lewandowski TA
    Hum Exp Toxicol; 2017 Aug; 36(8):846-853. PubMed ID: 27758843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients.
    Tse SA; Atayee RS; Best BM; Pesce AJ
    J Anal Toxicol; 2012 May; 36(4):221-31. PubMed ID: 22511696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of carisoprodol to breast milk.
    Nordeng H; Zahlsen K; Spigset O
    Ther Drug Monit; 2001 Jun; 23(3):298-300. PubMed ID: 11360042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.
    McIntyre IM; Sherrard J; Lucas J
    J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.
    Carbonaro TM; Nguyen V; Forster MJ; Gatch MB; Prokai L
    Neuropharmacology; 2020 Sep; 174():108152. PubMed ID: 32479814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study.
    Simon S; D'Andrea C; Wheeler WJ; Sacks H
    Curr Ther Res Clin Exp; 2010 Feb; 71(1):50-9. PubMed ID: 24683250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting carisoprodol metabolism in pain patients using urinary excretion data.
    Tse SA; Atayee RS; Ma JD; Best BM
    J Anal Toxicol; 2014 Apr; 38(3):122-8. PubMed ID: 24488112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
    Bramness JG; Skurtveit S; Fauske L; Grung M; Molven A; Mørland J; Steen VM
    Pharmacogenetics; 2003 Jul; 13(7):383-8. PubMed ID: 12835613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine.
    Wang G; Huynh K; Barhate R; Rodrigues W; Moore C; Coulter C; Vincent M; Soares J
    J Anal Toxicol; 2011 Mar; 35(2):108-12. PubMed ID: 21396230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carisoprodol (Soma): a new and cautious perspective on an old agent.
    Littrell RA; Hayes LR; Stillner V
    South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single and Multiple Dose PK-PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers.
    Calvo A; Alonso S; Prieto E; Ascaso-Del-Rio A; Ortuño J; Fernandez N; Portolés A
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects.
    Bramness JG; Skurtveit S; Gulliksen M; Breilid H; Steen VM; Mørland J
    Eur J Clin Pharmacol; 2005 Aug; 61(7):499-506. PubMed ID: 16021435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisoprodol concentrations from different anatomical sites: three overdose cases.
    Backer RC; Zumwalt R; McFeeley P; Veasey S; Wohlenberg N
    J Anal Toxicol; 1990; 14(5):332-4. PubMed ID: 2263072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C19 genetics in fatal carisoprodol intoxications.
    Høiseth G; Majid U; Mørland J; Bramness JG; Molden E
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1561-5. PubMed ID: 22527345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of carisoprodol and meprobamate in oral fluid.
    Coulter C; Garnier M; Tuyay J; Orbita J; Moore C
    J Anal Toxicol; 2012 Apr; 36(3):217-20. PubMed ID: 22417839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose carisoprodol during pregnancy and lactation.
    Briggs GG; Ambrose PJ; Nageotte MP; Padilla G
    Ann Pharmacother; 2008 Jun; 42(6):898-901. PubMed ID: 18460586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():105-14. PubMed ID: 26660179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.